PERSIST
Enrolling by invitation
178 enrolled
PROSTest_STRAT
Not yet recruiting
1,500 enrolled
VAPOR-LTR
Not yet recruiting
2,500 enrolled
PSMAreal
Recruiting
170 enrolled
DAROL
Active not recruiting
805 enrolled
CONCORD
Recruiting
400 enrolled
DP-04
Recruiting
100 enrolled
Double-DARE
Recruiting
1,400 enrolled
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Active not recruiting
60 enrolled
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Completed
1,083 enrolled 29 charts
ROAD
Not yet recruiting
1,600 enrolled
PRISME
Completed
831 enrolled
CAMPERR
Recruiting
7,000 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Completed
3,017 enrolled 5 charts
Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Recruiting
500 enrolled
PRIME
Recruiting
400 enrolled
BARVANA LONG
Completed
70 enrolled
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Completed
979 enrolled
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
Completed
1,300 enrolled
A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.
Active not recruiting
1 enrolled
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
CLP-10441
Active not recruiting
80 enrolled
BP-008
Completed
20 enrolled
CLP-10095
Completed
175 enrolled
PREDICT
Not yet recruiting
66 enrolled
OPTYX
Active not recruiting
999 enrolled
OLAP
Completed
661 enrolled
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely
Completed
13,779 enrolled
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
Active not recruiting
500 enrolled
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Terminated
120 enrolled
LOCUS
Not yet recruiting
64 enrolled
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Completed
2,313 enrolled 5 charts
APCaRI-05
Active not recruiting
2,800 enrolled
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
Completed
14 enrolled 11 charts
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
Completed
374 enrolled
Evaluation of Prostate Cancer Margins
Completed
100 enrolled
ES-HIFU
Terminated
14 enrolled
PROCeed-BR
Withdrawn
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Withdrawn
REAAcT
Completed
108 enrolled
TOGETHER
Withdrawn
A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death
Completed
6,908 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study
Completed
1,020 enrolled
TRUMPET
Completed
1,030 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled